Chemical science news from across RSC Publishing.
Cancer-fighting bone implants
01 October 2009
Bone-like materials can be used both as bone fillers and drug delivery vehicles for targeting bone cancers, claim Italian scientists. The materials release the drugs over a prolonged period and make them work better than the free drug.
Norberto Roveri, at the University of Bologna, Italy, and colleagues combined a synthetic bone substitute called hydroxyapatite (HA) with anticancer platinum complexes to produce implantable devices that can control the drugs' release and improve their cytotoxicity. The team hope that by releasing drugs only at target areas, they will be able to avoid the side effects common with anticancer medication.

By releasing drugs only at target areas, the side effects common with anticancer medication might be avoided |
The group examined the adsorption and release kinetics of platinum complexes on two types of HA nanocrystals, with different sizes, shapes and crystallinities. They found that the nanocrystals absorbed and released the complexes at different rates and in different amounts.
'The HA nanocrystals are able to release antitumoral platinum drugs right on the site of an osteosarcoma [bone cancer] in a slow and controlled manner,' Roveri explains, adding that the HA-drug conjugate is more effective than the free platinum complex.
'This is a fascinating study that shows the power of combining nanomineralogy and organometallic chemistry, in this case designed for an antitumoral application,' enthuses Michael Hochella, an expert in nanoscience at Virginia Tech, Blacksburg, US.
'It is the next stage that will be critical, and where many current drug delivery systems fail,' cautions Martin Garnett, an expert on drug-delivery systems at the University of Nottingham, UK. 'Can enough drug be loaded into the system to have a therapeutic effect?'
Roveri is confident that the system will be effective. 'The large surface area of the nanosized HA particles allows loading of a lot of Pt complex,' he says. Combined with their higher toxicity compared to the non-adsorbed complexes, this smart drug release mechanism should allow a very strong therapeutic effect in situ for a long time, he adds.
Edward Morgan
Enjoy this story? Spread the word using the 'tools' menu on the left or add a comment to the Chemistry World blog
Link to journal article
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals
Michele Iafisco, Barbara Palazzo, Marco Marchetti, Nicola Margiotta, Rosa Ostuni, Giovanni Natile, Margherita Morpurgo, Valentina Gandin, Cristina Marzano and Norberto Roveri, J. Mater. Chem., 2009, 19, 8385
DOI: 10.1039/b914379c
Also of interest
Back to basics for drug delivery
Colon cancer drug could reach its target without being destroyed by stomach acid
Chinese scientists have found a new route to the perfect smile, using nanoparticles to repair tooth enamel.
